Table 2.
Evaluation of efficacy 6 mo after transcatheter arterial chemoembolization according to the modified response evaluation criteria in solid tumors criteria
| CR | PR | SD | PD | Total | |
| All nodules | 81 | 26 | 13 | 7 | 127 |
| (63.8) | (20.5) | (10.2) | (5.5) | ||
| Anterior segment | 26 | 7 | 5 | 1 | 39 |
| Posterior segment | 22 | 8 | 3 | 4 | 37 |
| Medial segment | 14 | 8 | 4 | 1 | 27 |
| Lateral segment | 19 | 3 | 1 | 1 | 24 |
| Patient with Child-Pugh grade A | 56 | 17 | 10 | 3 | 86 |
| (65.1) | (19.8) | (11.6) | (3.5) | ||
| Anterior segment | 19 | 5 | 5 | 1 | 30 |
| Posterior segment | 14 | 5 | 1 | 1 | 21 |
| Medial segment | 9 | 6 | 3 | 0 | 18 |
| Lateral segment | 14 | 1 | 1 | 1 | 17 |
| Patients with Child-Pugh grade B | 25 | 9 | 3 | 4 | 41 |
| (61.0) | (22.0) | (7.3) | (9.7) | ||
| Anterior segment | 7 | 2 | 0 | 0 | 9 |
| Posterior segment | 8 | 3 | 2 | 3 | 16 |
| Medial segment | 5 | 2 | 1 | 1 | 9 |
| Lateral segment | 5 | 2 | 0 | 0 | 7 |
TACE: Transarterial chemoembolization; CR: Complete response; PR ± Partial response; SD: Stable disease; PD: Progressive disease.